91 related articles for article (PubMed ID: 32988392)
1. Immunosequencing applications in cutaneous T-cell lymphoma.
Mandel J; Gleason L; Joffe D; Bhatti S; Nikbakht N
Front Immunol; 2023; 14():1300061. PubMed ID: 38213330
[TBL] [Abstract][Full Text] [Related]
2. CD27/CD70 pathway activation in primary cutaneous CD4+ small/medium T-cell lymphoproliferative disorder.
Richter J; Oschlies I; Kock K; Wüseke T; Haag J; Koch K; Klapper W
J Pathol; 2024 Feb; 262(2):189-197. PubMed ID: 37933684
[TBL] [Abstract][Full Text] [Related]
3. Two cases of mycosis fungoides with large cell transformation with KMT2A rearrangements.
Wadsworth PA; Lawrence L; Suarez CJ; Saleem A; Khodadoust MS; Kim YH; Rieger KE; Fernandez-Pol S
J Hematop; 2023 Dec; 16(4):227-234. PubMed ID: 38175436
[TBL] [Abstract][Full Text] [Related]
4. Role of Antigenic Stimulation in Cutaneous T-Cell Lymphomas.
Gumina ME; Hooper MJ; Zhou XA; Koralov SB
J Invest Dermatol; 2024 Apr; 144(4):755-763. PubMed ID: 38149950
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of T-cell clonality by anti-TRBC1 antibody-based flow cytometry and correlation with T-cell receptor sequencing.
Nguyen PC; Nguyen T; Wilson C; Tiong IS; Baldwin K; Nguyen V; Came N; Blombery P; Westerman DA
Br J Haematol; 2024 Mar; 204(3):910-920. PubMed ID: 38098188
[TBL] [Abstract][Full Text] [Related]
6. Transformation of CLL to ALCL: the role of clonality studies in diagnostic molecular haematopathology.
Colling R; Royston D; Soilleux E
J Hematop; 2016 Sep; 9(3):143-147. PubMed ID: 27766121
[TBL] [Abstract][Full Text] [Related]
7. Diagnostic and prognostic molecular pathology of lymphoid malignancies.
Fend F; van den Brand M; Groenen PJ; Quintanilla-Martinez L; Bagg A
Virchows Arch; 2024 Feb; 484(2):195-214. PubMed ID: 37747559
[TBL] [Abstract][Full Text] [Related]
8. Application of automated machine learning for histological evaluation of feline endoscopic samples.
Ii T; Chambers JK; Nakashima K; Goto-Koshino Y; Uchida K
J Vet Med Sci; 2024 Feb; 86(2):160-167. PubMed ID: 38104975
[TBL] [Abstract][Full Text] [Related]
9. The synergistic proapoptotic effect of PARP-1 and HDAC inhibition in cutaneous T-cell lymphoma is mediated via Blimp-1.
Kruglov O; Wu X; Hwang ST; Akilov OE
Blood Adv; 2020 Oct; 4(19):4788-4797. PubMed ID: 33017467
[TBL] [Abstract][Full Text] [Related]
10. Unmasking a T cell lymphoma: Folliculotropic mycosis fungoides with a gamma-delta phenotype.
Tran J; Vega F; Duvic M
JAAD Case Rep; 2020 Dec; 6(12):1316-1319. PubMed ID: 32989422
[No Abstract] [Full Text] [Related]
11. Phenotypical Markers, Molecular Mutations, and Immune Microenvironment as Targets for New Treatments in Patients with Mycosis Fungoides and/or Sézary Syndrome.
Quaglino P; Fava P; Pileri A; Grandi V; Sanlorenzo M; Panasiti V; Guglielmo A; Alberti-Violetti S; Novelli M; Astrua C; Rubatto M; Tonella L; Berti E; Pimpinelli N; Osella Abate S; Fierro MT; Vermeer M; Scarisbrick JJ; Ribero S
J Invest Dermatol; 2021 Mar; 141(3):484-495. PubMed ID: 33162051
[TBL] [Abstract][Full Text] [Related]
12. Pembrolizumab in mycosis fungoides with PD-L1 structural variants.
Beygi S; Fernandez-Pol S; Duran G; Wang EB; Stehr H; Zehnder JL; Ramchurren N; Fling SP; Cheever MA; Weng WK; Kim YH; Khodadoust MS
Blood Adv; 2021 Feb; 5(3):771-774. PubMed ID: 33560388
[TBL] [Abstract][Full Text] [Related]
13. Mycosis fungoides and Sézary syndrome.
Lee H
Blood Res; 2023 Apr; 58(S1):66-82. PubMed ID: 37105561
[TBL] [Abstract][Full Text] [Related]
14. Cutaneous T-cell lymphomas: 2023 update on diagnosis, risk-stratification, and management.
Hristov AC; Tejasvi T; Wilcox RA
Am J Hematol; 2023 Jan; 98(1):193-209. PubMed ID: 36226409
[TBL] [Abstract][Full Text] [Related]
15. The Microenvironment's Role in Mycosis Fungoides and Sézary Syndrome: From Progression to Therapeutic Implications.
Pileri A; Guglielmo A; Grandi V; Violetti SA; Fanoni D; Fava P; Agostinelli C; Berti E; Quaglino P; Pimpinelli N
Cells; 2021 Oct; 10(10):. PubMed ID: 34685762
[TBL] [Abstract][Full Text] [Related]
16. Cutaneous T-cell lymphomas: 2021 update on diagnosis, risk-stratification, and management.
Hristov AC; Tejasvi T; A Wilcox R
Am J Hematol; 2021 Oct; 96(10):1313-1328. PubMed ID: 34297414
[TBL] [Abstract][Full Text] [Related]
17. Cutaneous T-cell lymphomas with pathogenic somatic mutations and absence of detectable clonal T-cell receptor gene rearrangement: two case reports.
Rojansky R; Fernandez-Pol S; Wang E; Rieger KE; Novoa RA; Zehnder JL; Kunder CA; Kim YH; Khodadoust MS; Brown RA
Diagn Pathol; 2020 Sep; 15(1):122. PubMed ID: 32988392
[TBL] [Abstract][Full Text] [Related]
18. New insights into the applicability of T-cell receptor gamma gene rearrangement analysis in cutaneous T-cell lymphoma.
Li N; Bhawan J
J Cutan Pathol; 2001 Sep; 28(8):412-8. PubMed ID: 11493379
[TBL] [Abstract][Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
